OssDsign Gains 510(k) for Indication in Interbody Cages
The FDA 510(k) clearance allows surgeons to use OssDsign Catalyst on-label in any interbody cage cleared for use with synthetic bone grafts. Sep 18, 2023
Stryker’s Pangea Trauma Systems Receive FDA Clearance
Stryker's Pangea Systems include applications to address the Femur, Fibula, Tibia, Humerus and Utility. Sep 13, 2023
Aurora Spine Fully Launches SiLO TFX MIS SI Joint Fixation
SiLO TFX MIS Sacroiliac Joint Fixation is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis. Sep 13, 2023
Prospective Episealer Talus Clinical Study Fully Recruited
The study will follow 20 recipients of an Episealer Talus implant as treatment for osteochondral defects in their ankle joint. Sep 13, 2023
2,000 Patients Treated with OssDsign Catalyst in the U.S.
OssDsign Catalyst is a nanosynthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion. Sep 13, 2023
Orthofix Announces Leadership Changes
Interim appointments have been made for the positions of Chief Executive Officer, Chief Financial Officer and Chief Legal Officer. Sep 12, 2023
Treace Medical Concepts Grows Bunion Treatment Offerings
These products will be available in limited U.S. market release through Treace’s bunion-focused sales team, with full market launch slated for 4Q23. Sep 12, 2023
OrthoPediatrics Gains 510(k) for Pediatric Nailing Platform | Tibia
The PNP Tibia represents another pediatric-focused solution for treating patients with fractures and deformities in the lower extremities. Sep 12, 2023
Bioretec Enters Distribution Agreement for RemeOs Screws
The distribution agreement with Spartan Medical signals the rollout of RemeOs screws in the United States. Sep 12, 2023
Sparta Biomedical Raises Funds for Knee OA Treatment
Sparta's Ormi device received FDA's Breakthrough Device Designation in 2021 to treat knee osteoarthritis. Sep 12, 2023
